to approve that EARTH underwent a business rehabilitation process.  The SEC, then, had a question regarding the existence and status of the increased debt of THB 26,000 million.The investigation

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the

electronically by us under 1.2 can be referred to as evidence in legal proceedings and we shall not deny the existence of such information only because it is in an electronic form. 2 . We acknowledge and agree

Directors had resolved to approve that EARTH underwent a business rehabilitation process.  The SEC, then, had a question regarding the existence and status of the increase debt of THB 26,000 million

than the previous year due to: the costs of domestic logistics business and dialysis manufacturing business which there had been none in 2017 due to no existence of such business; the expansion of